Literature DB >> 10873631

Complex formation between hepatitis C virus core protein and p21Waf1/Cip1/Sdi1.

F Wang1, I Yoshida, M Takamatsu, S Ishido, T Fujita, K Oka, H Hotta.   

Abstract

The core protein (Core) of hepatitis C virus (HCV) has been known to play an important role in hepatocarcinogenesis. By using glutathione S-transferase (GST) pull-down assay, we show here that Core formed a complex with p21Waf1/Cip1/Sdi1 (p21) cell cycle regulator. The deletion-mapping analysis revealed that a portion near the N-terminus of Core (amino acids 24-52) and a C-terminal portion of p21 (amino acids 139-164) were involved in the complex formation. The complex formation was not impaired by point mutations of p21 at residues 147, 149, and 150, which have been reported to abrogate interaction of p21 with proliferating cell nuclear antigen (PCNA), discriminating the Core-binding sequence from the PCNA-binding sequence. Due to the close vicinity of the binding sites, however, Core and PCNA competed with each other when interacting with p21. The distinct interaction between Core and p21 may provide a new aspect to the studies of HCV pathogenesis. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873631     DOI: 10.1006/bbrc.2000.2970

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division.

Authors:  T Wurm; H Chen; T Hodgson; P Britton; G Brooks; J A Hiscox
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis.

Authors:  Frank Scholle; Kui Li; Francis Bodola; Masanori Ikeda; Bruce A Luxon; Stanley M Lemon
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

3.  Oncogenic potential of hepatitis C virus proteins.

Authors:  Arup Banerjee; Ratna B Ray; Ranjit Ray
Journal:  Viruses       Date:  2010-09-27       Impact factor: 5.818

Review 4.  Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.

Authors:  Monica Marra; Ignazio M Sordelli; Angela Lombardi; Monica Lamberti; Luciano Tarantino; Aldo Giudice; Paola Stiuso; Alberto Abbruzzese; Rossella Sperlongano; Marina Accardo; Massimo Agresti; Michele Caraglia; Pasquale Sperlongano
Journal:  J Transl Med       Date:  2011-10-10       Impact factor: 5.531

Review 5.  Breaking Bad: How Viruses Subvert the Cell Cycle.

Authors:  Ying Fan; Sumana Sanyal; Roberto Bruzzone
Journal:  Front Cell Infect Microbiol       Date:  2018-11-19       Impact factor: 5.293

6.  The Immunogenicity in Mice of HCV Core Delivered as DNA Is Modulated by Its Capacity to Induce Oxidative Stress and Oxidative Stress Response.

Authors:  Juris Jansons; Irina Sominskaya; Natalia Petrakova; Elizaveta S Starodubova; Olga A Smirnova; Ekaterina Alekseeva; Ruta Bruvere; Olesja Eliseeva; Dace Skrastina; Elena Kashuba; Marija Mihailova; Sergey N Kochetkov; Alexander V Ivanov; Maria G Isaguliants
Journal:  Cells       Date:  2019-02-28       Impact factor: 6.600

Review 7.  Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences.

Authors:  Zakaria Boulahtouf; Alessia Virzì; Thomas F Baumert; Eloi R Verrier; Joachim Lupberger
Journal:  Int J Mol Sci       Date:  2022-03-03       Impact factor: 6.208

Review 8.  Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis.

Authors:  Alexander V Ivanov; Vladimir T Valuev-Elliston; Daria A Tyurina; Olga N Ivanova; Sergey N Kochetkov; Birke Bartosch; Maria G Isaguliants
Journal:  Oncotarget       Date:  2017-01-17

Review 9.  Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis.

Authors:  Daniela Bender; Eberhard Hildt
Journal:  Int J Mol Sci       Date:  2019-09-19       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.